
Sign up to save your podcasts
Or


Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742
By Medscape4.3
2525 ratings
Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742

136 Listeners

699 Listeners

497 Listeners

169 Listeners

104 Listeners

884 Listeners

14 Listeners

16 Listeners

296 Listeners

259 Listeners

3,340 Listeners

1,150 Listeners

194 Listeners

92 Listeners

512 Listeners

366 Listeners

172 Listeners

60 Listeners

8 Listeners

429 Listeners